Hedge Fund - Miller Value Partners
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $0 | 0% | 0 | $17.86 |
2 | 2024 - Q4 (2024-12-31) | $241,338 | 0.1% | 10,950 | $18.19 |
3 | 2024 - Q3 (2024-09-30) | $197,319 | 0.11% | 10,950 | $17.50 |
4 | 2024 - Q2 (2024-06-30) | $177,937 | 0.11% | 10,950 | $15.40 |
5 | 2024 - Q1 (2024-03-31) | $163,676 | 0.1% | 11,600 | $12.61 |
6 | 2023 - Q4 (2023-12-31) | $139,896 | 0.08% | 13,400 | $9.34 |
7 | 2023 - Q3 (2023-09-30) | $145,095 | 0.09% | 14,225 | $9.31 |
8 | 2023 - Q2 (2023-06-30) | $618,492 | 0.4% | 82,137 | $8.11 |
9 | 2023 - Q1 (2023-03-31) | $34,778,588 | 2.17% | 3,929,784 | $9.89 |
10 | 2022 - Q4 (2022-12-31) | $46,940,886 | 3.02% | 5,147,027 | $8.73 |
11 | 2022 - Q3 (2022-09-30) | $74,687,000 | 4.53% | 9,254,875 | $8.84 |
12 | 2022 - Q2 (2022-06-30) | $70,196,000 | 3.56% | 9,334,590 | $8.71 |
13 | 2022 - Q1 (2022-03-31) | $94,451,000 | 3.03% | 10,058,739 | $8.35 |
14 | 2021 - Q4 (2021-12-31) | $77,373,000 | 2.11% | 9,659,519 | $9.03 |
15 | 2021 - Q3 (2021-09-30) | $94,947,000 | 2.2% | 9,748,129 | $9.36 |
16 | 2021 - Q2 (2021-06-30) | $108,265,000 | 2.57% | 10,935,783 | $10.58 |
17 | 2021 - Q1 (2021-03-31) | $121,794,000 | 3.15% | 10,554,065 | $11.47 |
18 | 2020 - Q4 (2020-12-31) | $68,898,000 | 2.09% | 7,139,700 | $9.58 |
19 | 2020 - Q3 (2020-09-30) | $72,923,000 | 2.61% | 8,093,698 | $10.58 |
20 | 2020 - Q2 (2020-06-30) | $96,796,000 | 4.29% | 7,850,472 | $11.31 |
21 | 2020 - Q1 (2020-03-31) | $71,107,000 | 4.57% | 7,918,362 | $10.25 |
22 | 2019 - Q4 (2019-12-31) | $96,374,000 | 3.41% | 9,834,067 | $8.93 |
23 | 2019 - Q3 (2019-09-30) | $58,419,000 | 2.34% | 8,491,152 | $7.66 |
24 | 2019 - Q2 (2019-06-30) | $59,997,000 | 2.28% | 6,500,252 | $12.06 |
25 | 2019 - Q1 (2019-03-31) | $71,227,000 | 2.82% | 4,542,532 | $17.63 |
26 | 2018 - Q4 (2018-12-31) | $60,320,000 | 2.73% | 3,911,802 | $20.50 |
27 | 2018 - Q3 (2018-09-30) | $84,123,000 | 2.71% | 3,905,452 | $23.22 |
28 | 2018 - Q2 (2018-06-30) | $62,955,000 | 2.35% | 2,588,612 | $20.39 |
29 | 2018 - Q1 (2018-03-31) | $37,512,000 | 1.56% | 2,194,972 | $19.52 |
30 | 2017 - Q4 (2017-12-31) | $9,780,000 | 0.41% | 516,112 | $15.04 |
The displayed share prices are average quarterly stock market prices.